<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2025-8-78-82</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-4364</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Криопрофилактика алопеции, индуцированной химиотерапией у онкобольных</article-title><trans-title-group xml:lang="en"><trans-title>Scalp cooling in the prevention of chemotherapyinduced alopecia of patients with cancer</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0238-6563</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шатохина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shatochina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шатохина Евгения Афанасьевна, д.м.н., профессор кафедры дерматовенерологии и косметологии; врач-дерматовенеролог клинико-диагностического отделения</p><p>Москва</p></bio><bio xml:lang="en"><p>Shatokhina Evgeniya A., DM Sci (habil.), associate professor at Dept of Dermatovenereology and Cosmetology; dermatovenereologist at Clinical and Diagnostic Dept</p><p>Moscow</p></bio><email xlink:type="simple">e.a.shatokhina@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6283-2310</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Потоцкая</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pototskaya</surname><given-names>L.  A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Потоцкая Лидия Аурелиевна, ординатор 1-го курса специализации „дерматовенерология“</p><p>Москва</p></bio><bio xml:lang="en"><p>Potockaya Lidiya A., 1st-year resident specializing in dermatovenereology</p><p>Moscow</p></bio><email xlink:type="simple">lidatt@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-7468-998X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Проценко</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Procenko</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Проценко Алексей Николаевич, к.м.н., доцент кафедры дерматовенерологии имени академика Ю.К. Скрипкина ИКМ</p><p>Москва</p></bio><bio xml:lang="en"><p>Protsenko Aleksey N., PhD Med, associate professor at Dept of Dermatovenereology named after Academician Yu.K. Skripkin of Institute</p><p>Moscow</p></bio><email xlink:type="simple">anprotsenko1972@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Медицинский научно-образовательный институт ФГБОУ ВО «Московский государственный университет имени М.В. Ломоносова»; Медицинский научно-образовательный институт ФГБОУ ВО «Московский государственный&#13;
университет имени М.В. Ломоносова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central State Medical Academy of the Administrative Department of the President of Russia; Medical Research and Education Institute of the Lomonosov Moscow State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central State Medical Academy of the Administrative Department of the President of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinical Medicine of N.I. Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>04</day><month>06</month><year>2025</year></pub-date><volume>0</volume><issue>8</issue><issue-title>Дерматология (1)</issue-title><fpage>78</fpage><lpage>82</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шатохина Е.А., Потоцкая Л.А., Проценко А.Н., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Шатохина Е.А., Потоцкая Л.А., Проценко А.Н.</copyright-holder><copyright-holder xml:lang="en">Shatochina E.A., Pototskaya L.A., Procenko A.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/4364">https://www.med-alphabet.com/jour/article/view/4364</self-uri><abstract><p>Противоопухолевая химиотерапия вызывает анагеновую алопецию путем раннего апоптоза кератиноцитов вфолликуле. Одним из наиболее эффективных методов профилактики цитотоксической алопецией является система охлаждения кожи волосистой части головы. Суть метода заключается в использовании охлаждающих материалов в момент введения химиотерапевтических препаратов для возникновения вазоконстрикции в области волосистой части головы, что в свою очередь ведет к снижению кровотока и лимфотока уфолликулов и вызывает уменьшение концентрации химиопрепарата в области охлаждения. В обзоре представлены актуальные данные по криопрофилактике алопеции, индуцированной химиотерапией, у пациентов с неметастазирующим раком молочной железы. Эффективность метода оценивалась как выпадение волос менее 50% и варьирует в средних пределах 50–70%, однако зависит от режима химиотерапии, времени экспозиции охлаждения кожи головы ииндивидуальных особенностей пациента. Самые эффективные показатели профилактики анагеновой алопеции были у пациентов, принимающих монотерапию таксанами. Среди неблагоприятных эффектов пациенты отмечали ощущения холода, головокружение, болезненность кожи головы и лица. Были изучены преимущества и недостатки метода.</p></abstract><trans-abstract xml:lang="en"><p>Chemotherapy causes Chemotherapy-induced alopecia by early apoptosis of keratinocytes in the follicle. One of the most effective methods of combating cytotoxic alopecia is the cooling system of the scalp. The essence of the method is to use cooling materials at the time of chemotherapy to cause vasoconstriction on the scalp, which in turn leads to a decrease in blood flow and lymph flow in the follicle and causes a decrease in the concentration of the chemotherapy drug in the cooling area. The review presents current data on cryoprophylaxis of chemotherapy-induced alopecia in patients with non-metastatic breast cancer. The success rate of the method was estimated for hair loss of less than 50%. The effectiveness of the method varies between 50–70%, but depends on the type and dose of the drug, the exposure time to scalp cooling, and the individual characteristics of the patient. The best treatment rates for anagenetic alopecia were in patients receiving taxane-based chemotherapy. Among the adverse effects, patients noted cold sensations, dizziness, and soreness of the scalp and face. The advantages and disadvantages of the method were studied.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>цитотоксическая алопеция</kwd><kwd>анагеновая алопеция</kwd><kwd>криопрофилактика</kwd><kwd>нежелательные явления химиотерапии</kwd><kwd>гипотермия волосистой части головы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cytotoxic alopecia</kwd><kwd>anagen alopecia</kwd><kwd>cryoprophylaxis</kwd><kwd>adverse events of chemotherapy</kwd><kwd>scalp cooling system</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Огнерубов Н.А., Барсуков С.В. Гипотермия кожи головы для профилактики алопеции, индуцированной химиотерапией при раке молочной железы. Современная онкология. 2023. Т. 25. № 4. С. 513–517. DOI: 10.26442/18151434.2023.4.202549</mixed-citation><mixed-citation xml:lang="en">Ognerubov N.A., Barsukov S.V. Hypothermia of the scalp for the prevention of alopecia induced by chemotherapy in breast cancer. Modern oncology. 2023. Vol. 25. No. 4. P. 513–517. (In Russ.). DOI: 10.26442/18151434.2023.4.202549</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Silva G.B., Ciccolini K., Donati A., Hurk C.V.D. Scalp cooling to prevent chemotherapy-induced alopecia. An Bras Dermatol. 2020. Vol. 95. N5. P. 631–637. DOI: 10.1016/j.abd.2020.03.005. Epub 2020 Jun 16. PMID: 32622629; PMCID: PMC7563013.</mixed-citation><mixed-citation xml:lang="en">Silva G.B., Ciccolini K., Donati A., Hurk C.V.D. Scalp cooling to prevent chemotherapy-induced alopecia. An Bras Dermatol. 2020. Vol. 95. N5. P. 631–637. DOI: 10.1016/j.abd.2020.03.005. Epub 2020 Jun 16. PMID: 32622629; PMCID: PMC7563013.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Полежаева И. С., Старцева Ж.А., Гольдберг В. Е., Попова Н.О. Опыт применения гипотермии волосистой части кожи головы для профилактики алопеции при проведении химиотерапии. Сибирский онкологический журнал. 2017. Т. 16. № 2. С. 66–70. DOI: 10.21294/18144861 2017 16 2 66 70. EDN YQRKBV.</mixed-citation><mixed-citation xml:lang="en">Polezhaeva I.S., Startseva Zh.A., Goldberg V.E., Popova N.O. Experience of using hypothermia of the scalp for the prevention of alopecia during chemotherapy. Siberian Journal of Oncology. 2017. Vol. 16. No. 2. Pp. 66–70. (In Russ.). DOI: 10.21294/18144861 2017 16 2 66 70. EDN YQRKBV.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Amarillo D., de Boni D., Cuello M. Chemotherapy, Alopecia, and Scalp Cooling Systems. Actas Dermosifiliogr. 2022. Vol. 113. N3. P. 278–283. English, Spanish. DOI: 10.1016/j.ad.2021.09.003. Epub 2021 Oct 12. PMID: 35526920.</mixed-citation><mixed-citation xml:lang="en">Amarillo D., de Boni D., Cuello M. Chemotherapy, Alopecia, and Scalp Cooling Systems. Actas Dermosifiliogr. 2022. Vol. 113. N3. P. 278–283. English, Spanish. DOI: 10.1016/j.ad.2021.09.003. Epub 2021 Oct 12. PMID: 35526920.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Dunnill C.J., Al-Tameemi W., Collett A., Haslam I.S., Georgopoulos N.T. A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention. Oncologist. 2018. Vol. 23. N1. P. 84–96. DOI: 10.1634/theoncologist.2017–0263. Epub 2017 Sep 26. PMID: 28951499; PMCID: PMC5759815.</mixed-citation><mixed-citation xml:lang="en">Dunnill C.J., Al-Tameemi W., Collett A., Haslam I.S., Georgopoulos N.T. A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention. Oncologist. 2018. Vol. 23. N1. P. 84–96. DOI: 10.1634/theoncologist.2017–0263. Epub 2017 Sep 26. PMID: 28951499; PMCID: PMC5759815.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Shin H., Jo S.J., Kim D.H., Kwon O., Myung S.K. Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis. Int J Cancer. 2015. Vol. 136. N5. P. E442–54. DOI: 10.1002/ijc.29115. Epub 2014 Aug 11. PMID: 25081068.</mixed-citation><mixed-citation xml:lang="en">Shin H., Jo S.J., Kim D.H., Kwon O., Myung S.K. Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis. Int J Cancer. 2015. Vol. 136. N5. P. E442–54. DOI: 10.1002/ijc.29115. Epub 2014 Aug 11. PMID: 25081068.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lacouture M.E., Sibaud V., Gerber P.A., van den Hurk C., Fernández-Peñas P., Santini D., Jahn F., Jordan K.; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines*. Ann Oncol. 2021. Vol. 32. N2. P. 157–170. DOI: 10.1016/j.annonc.2020.11.005. Epub 2020 Nov 25. PMID: 33248228.</mixed-citation><mixed-citation xml:lang="en">Lacouture M.E., Sibaud V., Gerber P.A., van den Hurk C., Fernández-Peñas P., Santini D., Jahn F., Jordan K.; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines*. Ann Oncol. 2021. Vol. 32. N2. P. 157–170. DOI: 10.1016/j.annonc.2020.11.005. Epub 2020 Nov 25. PMID: 33248228.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Boyle F.M. et al. (2018). Management of Alopecia Due to Cancer Therapies. In: Olver, I. (eds) The MASCC Textbook of Cancer Supportive Care and Survivorship. Springer, Cham. https://doi.org/10.1007/978 3 319 90990 5_38</mixed-citation><mixed-citation xml:lang="en">Boyle F.M. et al. (2018). Management of Alopecia Due to Cancer Therapies. In: Olver, I. (eds) The MASCC Textbook of Cancer Supportive Care and Survivorship. Springer, Cham. https://doi.org/10.1007/978 3 319 90990 5_38</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Wang S., Yang T., Shen A., Qiang W., Zhao Z., Zhang F. The scalp cooling therapy for hair loss in breast cancer patients undergoing chemotherapy: a systematic review and meta-analysis. Support Care Cancer. 2021. Vol. 29. N11. P. 6943–6956. DOI: 10.1007/s00520 021 06188 8. Epub 2021 Apr 13. PMID: 33847828.</mixed-citation><mixed-citation xml:lang="en">Wang S., Yang T., Shen A., Qiang W., Zhao Z., Zhang F. The scalp cooling therapy for hair loss in breast cancer patients undergoing chemotherapy: a systematic review and meta-analysis. Support Care Cancer. 2021. Vol. 29. N11. P. 6943–6956. DOI: 10.1007/s00520 021 06188 8. Epub 2021 Apr 13. PMID: 33847828.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Rzepecki A.K., Cheng H., McLellan B.N. Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy. J Am Acad Dermatol. 2018. Vol. 79. N3. P. 545–555. DOI: 10.1016/j.jaad.2018.04.046. Epub 2018 May 4. PMID: 29733938.</mixed-citation><mixed-citation xml:lang="en">Rzepecki A.K., Cheng H., McLellan B.N. Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy. J Am Acad Dermatol. 2018. Vol. 79. N3. P. 545–555. DOI: 10.1016/j.jaad.2018.04.046. Epub 2018 May 4. PMID: 29733938.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kang D., Kim I.R., Choi E.K., Im Y.H., Park Y.H., Ahn J. S., Lee J.E., Nam S. J., Lee H.K., Park J.H., Lee D.Y., Lacouture M.E., Guallar E., Cho J. Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study. Oncologist. 2019. Vol. 24. N3. P. 414–420. DOI: 10.1634/theoncologist.2018–0184. Epub 2018 Aug 17. PMID: 30120165; PMCID: PMC6519756.</mixed-citation><mixed-citation xml:lang="en">Kang D., Kim I.R., Choi E.K., Im Y.H., Park Y.H., Ahn J. S., Lee J.E., Nam S. J., Lee H.K., Park J.H., Lee D.Y., Lacouture M.E., Guallar E., Cho J. Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study. Oncologist. 2019. Vol. 24. N3. P. 414–420. DOI: 10.1634/theoncologist.2018–0184. Epub 2018 Aug 17. PMID: 30120165; PMCID: PMC6519756.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Freites-Martinez A., Chan D., Sibaud V., Shapiro J., Fabbrocini G., Tosti A., Cho J., Goldfarb S., Modi S., Gajria D., Norton L., Paus R., Cigler T., Lacouture M.E. Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia. JAMA Dermatol. 2019. Vol. 155. N6. P. 724–728. DOI: 10.1001/jamadermatol.2018.5071. PMID: 30840033; PMCID: PMC6563563.</mixed-citation><mixed-citation xml:lang="en">Freites-Martinez A., Chan D., Sibaud V., Shapiro J., Fabbrocini G., Tosti A., Cho J., Goldfarb S., Modi S., Gajria D., Norton L., Paus R., Cigler T., Lacouture M.E. Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia. JAMA Dermatol. 2019. Vol. 155. N6. P. 724–728. DOI: 10.1001/jamadermatol.2018.5071. PMID: 30840033; PMCID: PMC6563563.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Freites-Martinez A., Shapiro J., Goldfarb S., Nangia J., Jimenez J.J., Paus R., Lacouture M.E. Hair disorders in patients with cancer. J Am Acad Dermatol. 2019. Vol. 80. N5. P. 1179–1196. DOI: 10.1016/j.jaad.2018.03.055. Epub 2018 Apr 14. PMID: 29660422; PMCID: PMC6186204.</mixed-citation><mixed-citation xml:lang="en">Freites-Martinez A., Shapiro J., Goldfarb S., Nangia J., Jimenez J.J., Paus R., Lacouture M.E. Hair disorders in patients with cancer. J Am Acad Dermatol. 2019. Vol. 80. N5. P. 1179–1196. DOI: 10.1016/j.jaad.2018.03.055. Epub 2018 Apr 14. PMID: 29660422; PMCID: PMC6186204.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Rossi A., Caterina Fortuna M., Caro G., et al. Monitoring chemotherapy-induced alopecia with trichoscopy. J Cosmet Dermatol. 2019. Vol. 18. N2. P. 575–80. DOI:10.1111/jocd.12687</mixed-citation><mixed-citation xml:lang="en">Rossi A., Caterina Fortuna M., Caro G., et al. Monitoring chemotherapy-induced alopecia with trichoscopy. J Cosmet Dermatol. 2019. Vol. 18. N2. P. 575–80. DOI:10.1111/jocd.12687</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Freites-Martinez A., Shapiro J., van den Hurk C., Goldfarb S., Jimenez J.J., Rossi A.M., Paus R., Lacouture M.E. Hair disorders in cancer survivors. J Am Acad Dermatol. 2019. Vol. 80. N5. P. 1199– 1213. DOI: 10.1016/j.jaad.2018.03.056. Epub 2018 Apr 14. PMID: 29660423; PMCID: PMC6186205.</mixed-citation><mixed-citation xml:lang="en">Freites-Martinez A., Shapiro J., van den Hurk C., Goldfarb S., Jimenez J.J., Rossi A.M., Paus R., Lacouture M.E. Hair disorders in cancer survivors. J Am Acad Dermatol. 2019. Vol. 80. N5. P. 1199– 1213. DOI: 10.1016/j.jaad.2018.03.056. Epub 2018 Apr 14. PMID: 29660423; PMCID: PMC6186205.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Stoehr J.R., Kosche C., Choi J.N. Permanent chemotherapy-induced alopecia: awareness and attitudes among health care providers. Support Care Cancer. 2020. Vol. 28. N6. P. 2887–2890. DOI: 10.1007/s00520 019 05169 2. Epub 2019 Nov 19. PMID: 31745696.</mixed-citation><mixed-citation xml:lang="en">Stoehr J.R., Kosche C., Choi J.N. Permanent chemotherapy-induced alopecia: awareness and attitudes among health care providers. Support Care Cancer. 2020. Vol. 28. N6. P. 2887–2890. DOI: 10.1007/s00520 019 05169 2. Epub 2019 Nov 19. PMID: 31745696.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Martín M, de la Torre-Montero JC, López-Tarruella S, et al. Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling. Breast Cancer Res Treat. 2018. Vol. 171. N3. P. 627–634. DOI: 10.1007/s10549 018 4855 2. Epub 2018 Jun 19. Erratum in: Breast Cancer Res Treat. 2018 Oct;171(3):635–636. DOI: 10.1007/s10549–018–4883-y. PMID: 29923063; PMCID: PMC6133184.</mixed-citation><mixed-citation xml:lang="en">Martín M, de la Torre-Montero JC, López-Tarruella S, et al. Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling. Breast Cancer Res Treat. 2018. Vol. 171. N3. P. 627–634. DOI: 10.1007/s10549 018 4855 2. Epub 2018 Jun 19. Erratum in: Breast Cancer Res Treat. 2018 Oct;171(3):635–636. DOI: 10.1007/s10549–018–4883-y. PMID: 29923063; PMCID: PMC6133184.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wikramanayake TC, Haberland NI, Akhundlu A, et al. Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?. Curr Oncol. 2023. Vol. 30. N4. P. 3609–3626. DOI: 10.3390/curroncol30040275. PMID: 37185388; PMCID: PMC10137043.</mixed-citation><mixed-citation xml:lang="en">Wikramanayake TC, Haberland NI, Akhundlu A, et al. Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?. Curr Oncol. 2023. Vol. 30. N4. P. 3609–3626. DOI: 10.3390/curroncol30040275. PMID: 37185388; PMCID: PMC10137043.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Delgado Rodríguez J, Ramos-García V, Infante-Ventura D, et al. Ethical, legal, organizational and social issues related to the use of scalp cooling for the prevention of chemotherapy-induced alopecia: A systematic review. Health Expect. 2023. Vol. 26. N2. P. 567–578. DOI: 10.1111/hex.13679. Epub 2022 Dec 30. PMID: 36585793; PMCID: PMC10010082.</mixed-citation><mixed-citation xml:lang="en">Delgado Rodríguez J, Ramos-García V, Infante-Ventura D, et al. Ethical, legal, organizational and social issues related to the use of scalp cooling for the prevention of chemotherapy-induced alopecia: A systematic review. Health Expect. 2023. Vol. 26. N2. P. 567–578. DOI: 10.1111/hex.13679. Epub 2022 Dec 30. PMID: 36585793; PMCID: PMC10010082.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou T, Han S, Zhu Z, et al. Interventions for Preventing Chemotherapy-Induced Alopecia: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials. Cancer Nurs. 2021. Vol. 44. N6. P. E567-E577. DOI: 10.1097/NCC.0000000000000899. PMID: 33003120.</mixed-citation><mixed-citation xml:lang="en">Zhou T, Han S, Zhu Z, et al. Interventions for Preventing Chemotherapy-Induced Alopecia: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials. Cancer Nurs. 2021. Vol. 44. N6. P. E567-E577. DOI: 10.1097/NCC.0000000000000899. PMID: 33003120.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Saraswat N, Chopra A, Sood A, et al. A Descriptive Study to Analyze Chemotherapy-Induced Hair Loss and its Psychosocial Impact in Adults: Our Experience from a Tertiary Care Hospital. Indian Dermatol Online J. 2019. Vol. 10. N4. P. 426–430. DOI: 10.4103/idoj.IDOJ_471_18. PMID: 31334063; PMCID: PMC6615375.</mixed-citation><mixed-citation xml:lang="en">Saraswat N, Chopra A, Sood A, et al. A Descriptive Study to Analyze Chemotherapy-Induced Hair Loss and its Psychosocial Impact in Adults: Our Experience from a Tertiary Care Hospital. Indian Dermatol Online J. 2019. Vol. 10. N4. P. 426–430. DOI: 10.4103/idoj.IDOJ_471_18. PMID: 31334063; PMCID: PMC6615375.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Quesada S, Guichard A, Fiteni F. Cancer-Related Alopecia: From Etiologies to Global Management. Cancers (Basel). 2021. Vol. 13. N21. P. 5556. DOI: 10.3390/cancers13215556. PMID: 34771716; PMCID: PMC8583126.</mixed-citation><mixed-citation xml:lang="en">Quesada S, Guichard A, Fiteni F. Cancer-Related Alopecia: From Etiologies to Global Management. Cancers (Basel). 2021. Vol. 13. N21. P. 5556. DOI: 10.3390/cancers13215556. PMID: 34771716; PMCID: PMC8583126.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Haque E, Alabdaljabar MS, Ruddy KJ, et al. Management of chemotherapy-induced alopecia (CIA): A comprehensive review and future directions. Crit Rev Oncol Hematol. 2020. Vol. 156. P. 103093. DOI: 10.1016/j.critrevonc.2020.103093. Epub 2020 Sep 22. PMID: 33070077.</mixed-citation><mixed-citation xml:lang="en">Haque E, Alabdaljabar MS, Ruddy KJ, et al. Management of chemotherapy-induced alopecia (CIA): A comprehensive review and future directions. Crit Rev Oncol Hematol. 2020. Vol. 156. P. 103093. DOI: 10.1016/j.critrevonc.2020.103093. Epub 2020 Sep 22. PMID: 33070077.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Shen XF, Ru LX, Yao XB. Efficacy of scalp cooling for prevention of chemotherapy induced alopecia: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2021. Vol. 25. N16. P. 5090–5103. DOI: 10.26355/eurrev_202108_26520. PMID: 34486683.</mixed-citation><mixed-citation xml:lang="en">Shen XF, Ru LX, Yao XB. Efficacy of scalp cooling for prevention of chemotherapy induced alopecia: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2021. Vol. 25. N16. P. 5090–5103. DOI: 10.26355/eurrev_202108_26520. PMID: 34486683.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Skrok A, Bednarczuk T, Skwarek A, et al. The effect of parathyroid hormones on hair follicle physiology: implications for treatment of chemotherapy-induced alopecia. Skin Pharmacol Physiol. 2015. Vol. 28. N4. P. 213–225. DOI: 10.1159/000375319. PMID: 25721772.</mixed-citation><mixed-citation xml:lang="en">Skrok A, Bednarczuk T, Skwarek A, et al. The effect of parathyroid hormones on hair follicle physiology: implications for treatment of chemotherapy-induced alopecia. Skin Pharmacol Physiol. 2015. Vol. 28. N4. P. 213–225. DOI: 10.1159/000375319. PMID: 25721772.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Lacouture M.E., Dion H., Ravipaty S., et al. A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia. Breast Cancer Res Treat. 2021. Vol. 186. N1. P. 107–114. DOI: 10.1007/s10549 020 06005 6. Epub 2020 Nov 18. PMID: 33206291; PMCID: PMC8388155.</mixed-citation><mixed-citation xml:lang="en">Lacouture M.E., Dion H., Ravipaty S., et al. A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia. Breast Cancer Res Treat. 2021. Vol. 186. N1. P. 107–114. DOI: 10.1007/s10549 020 06005 6. Epub 2020 Nov 18. PMID: 33206291; PMCID: PMC8388155.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">FDA. FDA Clears Expanded Use of Cooling Cap to Reduce Hair Loss During Chemotherapy. U.S. Food and Drug Administration. [дата обращения 07.12.24]. Available from: [https://www.fda.gov/news-events/ press-announcements/fda-clears-expanded-use-cooling-cap-reduce-hair-loss-during-chemotherapy]</mixed-citation><mixed-citation xml:lang="en">FDA. FDA Clears Expanded Use of Cooling Cap to Reduce Hair Loss During Chemotherapy. U.S. Food and Drug Administration. [дата обращения 07.12.24]. Available from: [https://www.fda.gov/news-events/ press-announcements/fda-clears-expanded-use-cooling-cap-reduce-hair-loss-during-chemotherapy]</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Komen M.M., Smorenburg C.H., van den Hurk C.J., Nortier J.W. Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. Oncologist. 2013. Vol. 18. N7. P. 885–91. DOI: 10.1634/theoncologist.2012–0332. Epub 2013 May 6. PMID: 23650021; PMCID: PMC3720643.</mixed-citation><mixed-citation xml:lang="en">Komen M.M., Smorenburg C.H., van den Hurk C.J., Nortier J.W. Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. Oncologist. 2013. Vol. 18. N7. P. 885–91. DOI: 10.1634/theoncologist.2012–0332. Epub 2013 May 6. PMID: 23650021; PMCID: PMC3720643.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Shah V.V., Wikramanayake T. C., DelCanto G.M., van den Hurk C., Wu S., Lacouture M. E., Jimenez J.J. Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia: a review of controlled clinical trials. J Eur Acad Dermatol Venereol. 2018. Vol. 32. N5. P. 720–734. DOI: 10.1111/jdv.14612. Epub 2017 Nov 24. PMID: 28976026; PMCID: PMC8127610.</mixed-citation><mixed-citation xml:lang="en">Shah V.V., Wikramanayake T. C., DelCanto G.M., van den Hurk C., Wu S., Lacouture M. E., Jimenez J.J. Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia: a review of controlled clinical trials. J Eur Acad Dermatol Venereol. 2018. Vol. 32. N5. P. 720–734. DOI: 10.1111/jdv.14612. Epub 2017 Nov 24. PMID: 28976026; PMCID: PMC8127610.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Komen M.M.C., Smorenburg C.H., Nortier J.W.R., van der Ploeg T., van den Hurk C.J.G., van der Hoeven J.J.M. Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature. Breast. 2016. Vol. 30. P. 105–110. DOI: 10.1016/j.breast.2016.09.007. Epub 2016 Sep 28. PMID: 27689316.</mixed-citation><mixed-citation xml:lang="en">Komen M.M.C., Smorenburg C.H., Nortier J.W.R., van der Ploeg T., van den Hurk C.J.G., van der Hoeven J.J.M. Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature. Breast. 2016. Vol. 30. P. 105–110. DOI: 10.1016/j.breast.2016.09.007. Epub 2016 Sep 28. PMID: 27689316.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Carton E., Blas A.M., Perret C., Le Bihan M. Effectiveness of increasing the scalp cooling duration to prevent alopecia during adjuvant chemotherapy for breast cancer: a randomized pilot study. Support Care Cancer. 2024. Vol. 32. N7. P. 410. DOI: 10.1007/s00520–024–08579-z. PMID: 38839667; PMCID: PMC11153286.</mixed-citation><mixed-citation xml:lang="en">Carton E., Blas A.M., Perret C., Le Bihan M. Effectiveness of increasing the scalp cooling duration to prevent alopecia during adjuvant chemotherapy for breast cancer: a randomized pilot study. Support Care Cancer. 2024. Vol. 32. N7. P. 410. DOI: 10.1007/s00520–024–08579-z. PMID: 38839667; PMCID: PMC11153286.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">van den Hurk C.J., Breed W.P., Nortier J.W. Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer. 2012. Vol. 20. N12. P. 3255–60. DOI: 10.1007/s00520 012 1465 0. Epub 2012 Apr 27. PMID: 22539051.</mixed-citation><mixed-citation xml:lang="en">van den Hurk C.J., Breed W.P., Nortier J.W. Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer. 2012. Vol. 20. N12. P. 3255–60. DOI: 10.1007/s00520 012 1465 0. Epub 2012 Apr 27. PMID: 22539051.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Komen M.M., Breed W.P., Smorenburg C.H., van der Ploeg T., Goey S.H., van der Hoeven J.J., Nortier J.W., van den Hurk C.J. Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer. 2016. Vol. 24. N6. P. 2735–41. DOI: 10.1007/s00520 016 3084 7. Epub 2016 Jan 25. PMID: 26805558.</mixed-citation><mixed-citation xml:lang="en">Komen M.M., Breed W.P., Smorenburg C.H., van der Ploeg T., Goey S.H., van der Hoeven J.J., Nortier J.W., van den Hurk C.J. Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer. 2016. Vol. 24. N6. P. 2735–41. DOI: 10.1007/s00520 016 3084 7. Epub 2016 Jan 25. PMID: 26805558.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Komen M.M.C., van den Hurk C. J.G., Nortier J.W.R., van der Ploeg T., Nieboer P., van der Hoeven J.J.M., Smorenburg C.H. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy. Support Care Cancer. 2019. Vol. 27. N5. P. 1919–1925. DOI: 10.1007/s00520 018 4432 6. Epub 2018 Sep 11. PMID: 30206728.</mixed-citation><mixed-citation xml:lang="en">Komen M.M.C., van den Hurk C. J.G., Nortier J.W.R., van der Ploeg T., Nieboer P., van der Hoeven J.J.M., Smorenburg C.H. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy. Support Care Cancer. 2019. Vol. 27. N5. P. 1919–1925. DOI: 10.1007/s00520 018 4432 6. Epub 2018 Sep 11. PMID: 30206728.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Nangia J., Wang T., Osborne C., et al. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial. JAMA. 2017. Vol. 317. N6. P. 596–605. DOI: 10.1001/jama.2016.20939. PMID: 28196254.</mixed-citation><mixed-citation xml:lang="en">Nangia J., Wang T., Osborne C., et al. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial. JAMA. 2017. Vol. 317. N6. P. 596–605. DOI: 10.1001/jama.2016.20939. PMID: 28196254.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Rugo H.S., Klein P., Melin S.A., et al. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer. JAMA. 2017. Vol. 317. N6. P. 606–614. DOI: 10.1001/jama.2016.21038. PMID: 28196257; PMCID: PMC5639721.</mixed-citation><mixed-citation xml:lang="en">Rugo H.S., Klein P., Melin S.A., et al. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer. JAMA. 2017. Vol. 317. N6. P. 606–614. DOI: 10.1001/jama.2016.21038. PMID: 28196257; PMCID: PMC5639721.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Rubio-Gonzalez B., Juhász M., Fortman J., Mesinkovska N.A. Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review. Int J Dermatol. 2018. Vol. 57. N12. P. 1417–1424. DOI: 10.1111/ijd.13906. Epub 2018 Jan 29. PMID: 29377091.</mixed-citation><mixed-citation xml:lang="en">Rubio-Gonzalez B., Juhász M., Fortman J., Mesinkovska N.A. Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review. Int J Dermatol. 2018. Vol. 57. N12. P. 1417–1424. DOI: 10.1111/ijd.13906. Epub 2018 Jan 29. PMID: 29377091.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Smetanay K., Junio P., Feißt M., et al. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer. Breast Cancer Res Treat. 2019. Vol. 173. N1. P. 135–143. DOI: 10.1007/s10549 018 4983 8. Epub 2018 Sep 25. PMID: 30255454.</mixed-citation><mixed-citation xml:lang="en">Smetanay K., Junio P., Feißt M., et al. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer. Breast Cancer Res Treat. 2019. Vol. 173. N1. P. 135–143. DOI: 10.1007/s10549 018 4983 8. Epub 2018 Sep 25. PMID: 30255454.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Munzone E., Bagnardi V., Campennì G., et al. Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines. Br J Cancer. 2019. Vol. 121. N4. P. 325–331. DOI: 10.1038/s41416 019 0520 8. Epub 2019 Jul 15. PMID: 31303642; PMCID: PMC6738323.</mixed-citation><mixed-citation xml:lang="en">Munzone E., Bagnardi V., Campennì G., et al. Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines. Br J Cancer. 2019. Vol. 121. N4. P. 325–331. DOI: 10.1038/s41416 019 0520 8. Epub 2019 Jul 15. PMID: 31303642; PMCID: PMC6738323.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Giarratano T., Frezzini S., Zanocco M., et al. Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study. Breast J. 2020. Vol. 26. N7. P. 1296–1301. DOI: 10.1111/tbj.13711. Epub 2019 Dec 14. PMID: 31837103.</mixed-citation><mixed-citation xml:lang="en">Giarratano T., Frezzini S., Zanocco M., et al. Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study. Breast J. 2020. Vol. 26. N7. P. 1296–1301. DOI: 10.1111/tbj.13711. Epub 2019 Dec 14. PMID: 31837103.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">van den Hurk C. J., Peerbooms M., van de Poll-Franse L.V., Nortier J. W., Coebergh J.W., Breed W.P. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients – results of the Dutch Scalp Cooling Registry. Acta Oncol. 2012. Vol. 51. N4. P. 497–504. DOI: 10.3109/0284186X.2012.658966. Epub 2012 Feb 6. PMID: 22304489.</mixed-citation><mixed-citation xml:lang="en">van den Hurk C. J., Peerbooms M., van de Poll-Franse L.V., Nortier J. W., Coebergh J.W., Breed W.P. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients – results of the Dutch Scalp Cooling Registry. Acta Oncol. 2012. Vol. 51. N4. P. 497–504. DOI: 10.3109/0284186X.2012.658966. Epub 2012 Feb 6. PMID: 22304489.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Rugo H.S., et al. Clinical performance of the DigniCap system, a scalp hypothermia system, in preventing chemotherapy-induced alopecia. ASCO Meeting Abstr. 2015. Vol. 33. P. 9518.</mixed-citation><mixed-citation xml:lang="en">Rugo H.S., et al. Clinical performance of the DigniCap system, a scalp hypothermia system, in preventing chemotherapy-induced alopecia. ASCO Meeting Abstr. 2015. Vol. 33. P. 9518.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Rugo H.S., Melin S.A., Voigt J. Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis. Breast Cancer Res Treat. 2017. Vol. 163. N2. P. 199–205. DOI: 10.1007/s10549 017 4185 9. Epub 2017 Mar 8. PMID: 28275922; PMCID: PMC5410200.</mixed-citation><mixed-citation xml:lang="en">Rugo H.S., Melin S.A., Voigt J. Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis. Breast Cancer Res Treat. 2017. Vol. 163. N2. P. 199–205. DOI: 10.1007/s10549 017 4185 9. Epub 2017 Mar 8. PMID: 28275922; PMCID: PMC5410200.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Rugo H.S., Voigt J. Scalp Hypothermia for Preventing Alopecia During Chemotherapy. A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clin Breast Cancer. 2018. Vol. 18. N1. P. 19–28. DOI: 10.1016/j.clbc.2017.07.012. Epub 2017 Aug 10. PMID: 28939291.</mixed-citation><mixed-citation xml:lang="en">Rugo H.S., Voigt J. Scalp Hypothermia for Preventing Alopecia During Chemotherapy. A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clin Breast Cancer. 2018. Vol. 18. N1. P. 19–28. DOI: 10.1016/j.clbc.2017.07.012. Epub 2017 Aug 10. PMID: 28939291.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Kadakia K.C., Rozell S.A., Butala A.A., Loprinzi C. L. Supportive cryotherapy: a review from head to toe. J Pain Symptom Manage. 2014. Vol. 47. N6. P. 1100–15. DOI: 10.1016/j.jpainsymman.2013.07.014. Epub 2013 Nov 7. PMID: 24210702; PMCID: PMC4013268.</mixed-citation><mixed-citation xml:lang="en">Kadakia K.C., Rozell S.A., Butala A.A., Loprinzi C. L. Supportive cryotherapy: a review from head to toe. J Pain Symptom Manage. 2014. Vol. 47. N6. P. 1100–15. DOI: 10.1016/j.jpainsymman.2013.07.014. Epub 2013 Nov 7. PMID: 24210702; PMCID: PMC4013268.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Heibloem R.E., Komen M.M.C., Ilozumba O.U.C., van den Hurk C.J.G. Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients – results from the Dutch Scalp Cooling Registry. Support Care Cancer. 2023. Vol. 31. N5. P. 273. DOI: 10.1007/s00520 023 07687 6. PMID: 37067605.</mixed-citation><mixed-citation xml:lang="en">Heibloem R.E., Komen M.M.C., Ilozumba O.U.C., van den Hurk C.J.G. Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients – results from the Dutch Scalp Cooling Registry. Support Care Cancer. 2023. Vol. 31. N5. P. 273. DOI: 10.1007/s00520 023 07687 6. PMID: 37067605.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Kanat O., Ertas H., Caner B. Platinum-induced neurotoxicity: A review of possible mechanisms. World J Clin Oncol. 2017. Vol. 8. N4. P. 329–335. DOI: 10.5306/wjco.v8.i4.329. PMID: 28848699; PMCID: PMC5554876.</mixed-citation><mixed-citation xml:lang="en">Kanat O., Ertas H., Caner B. Platinum-induced neurotoxicity: A review of possible mechanisms. World J Clin Oncol. 2017. Vol. 8. N4. P. 329–335. DOI: 10.5306/wjco.v8.i4.329. PMID: 28848699; PMCID: PMC5554876.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Rossi A., Caro G., Fortuna M.C., Pigliacelli F., D’Arino A., Carlesimo M. Prevention and Treatment of Chemotherapy-Induced Alopecia. Dermatol Pract Concept. 2020. Vol. 10. N3. P. e2020074. DOI: 10.5826/dpc.1003a74. PMID: 32642317; PMCID: PMC7319796.</mixed-citation><mixed-citation xml:lang="en">Rossi A., Caro G., Fortuna M.C., Pigliacelli F., D’Arino A., Carlesimo M. Prevention and Treatment of Chemotherapy-Induced Alopecia. Dermatol Pract Concept. 2020. Vol. 10. N3. P. e2020074. DOI: 10.5826/dpc.1003a74. PMID: 32642317; PMCID: PMC7319796.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Marks D.H., Okhovat J.P., Hagigeorges D., Manatis-Lornell A.J., Isakoff S.J., Lacouture M.E., Senna M.M. The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review. Breast Cancer Res Treat. 2019. Vol. 175. N2. P. 267–276. DOI: 10.1007/s10549 019 05169 0. Epub 2019 Feb 26. PMID: 30806923.</mixed-citation><mixed-citation xml:lang="en">Marks D.H., Okhovat J.P., Hagigeorges D., Manatis-Lornell A.J., Isakoff S.J., Lacouture M.E., Senna M.M. The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review. Breast Cancer Res Treat. 2019. Vol. 175. N2. P. 267–276. DOI: 10.1007/s10549 019 05169 0. Epub 2019 Feb 26. PMID: 30806923.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Carbognin L., Accetta C., Di Giorgio D., et al. Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo) Adjuvant Chemotherapy for Breast Cancer. Curr Oncol. 2022. Vol. 30;29(10). P. 7218–7228. DOI: 10.3390/curroncol29100569. PMID: 36290846. PMCID: PMC9600590.</mixed-citation><mixed-citation xml:lang="en">Carbognin L., Accetta C., Di Giorgio D., et al. Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo) Adjuvant Chemotherapy for Breast Cancer. Curr Oncol. 2022. Vol. 30;29(10). P. 7218–7228. DOI: 10.3390/curroncol29100569. PMID: 36290846. PMCID: PMC9600590.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
